WO2006084914A3 - Device for gastric treatment and manufacturing process for the same - Google Patents

Device for gastric treatment and manufacturing process for the same Download PDF

Info

Publication number
WO2006084914A3
WO2006084914A3 PCT/EP2006/050894 EP2006050894W WO2006084914A3 WO 2006084914 A3 WO2006084914 A3 WO 2006084914A3 EP 2006050894 W EP2006050894 W EP 2006050894W WO 2006084914 A3 WO2006084914 A3 WO 2006084914A3
Authority
WO
WIPO (PCT)
Prior art keywords
nitric oxide
same
manufacturing process
eluting polymer
gastric
Prior art date
Application number
PCT/EP2006/050894
Other languages
French (fr)
Other versions
WO2006084914A2 (en
Inventor
Tor Peters
Original Assignee
Nolabs Ab
Tor Peters
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05002933A external-priority patent/EP1690532A1/en
Application filed by Nolabs Ab, Tor Peters filed Critical Nolabs Ab
Publication of WO2006084914A2 publication Critical patent/WO2006084914A2/en
Publication of WO2006084914A3 publication Critical patent/WO2006084914A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

A device is provided that allows for target treatment of gastric and gastrointestinal complications, including gastric ulcer. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the area to be treated, such that a therapeutic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said area. The nitric oxide (NO) eluting polymer is integrated with a carrier material, such that said carrier material, in use, regulates and controls the elution of said therapeutic dosage of nitric oxide (NO). Furthermore, a manufacturing method for said device is disclosed.
PCT/EP2006/050894 2005-02-11 2006-02-13 Device for gastric treatment and manufacturing process for the same WO2006084914A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05002933.9 2005-02-11
EP05002933A EP1690532A1 (en) 2005-02-11 2005-02-11 Device for gastric treatment and manufacturing process for the same
US65276105P 2005-02-14 2005-02-14
US60/652,761 2005-02-14

Publications (2)

Publication Number Publication Date
WO2006084914A2 WO2006084914A2 (en) 2006-08-17
WO2006084914A3 true WO2006084914A3 (en) 2006-11-16

Family

ID=36684334

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/050894 WO2006084914A2 (en) 2005-02-11 2006-02-13 Device for gastric treatment and manufacturing process for the same

Country Status (1)

Country Link
WO (1) WO2006084914A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9526738B2 (en) 2009-08-21 2016-12-27 Novan, Inc. Topical gels and methods of using the same

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5274248B2 (en) 2005-05-27 2013-08-28 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル Nitric oxide releasing particles for nitric oxide therapy and biomedical applications
WO2009049208A1 (en) * 2007-10-12 2009-04-16 The University Of North Carolina At Chapel Hill Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
GB0821345D0 (en) 2008-11-21 2008-12-31 P Q Silicas Uk Ltd Composition and dressing with nitric oxide
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
EP2681286B1 (en) 2011-02-28 2018-08-15 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
GB2539698A (en) 2015-06-25 2016-12-28 Heart Biotech Pharma Ltd Heart Biotech Pharma Limited

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2106105A1 (en) * 1993-09-14 1995-03-15 Larry K. Keefer Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
WO1995024908A1 (en) * 1994-03-17 1995-09-21 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of nitric oxide-releasing polymers to treat restenosis and related disorders
WO1996015797A1 (en) * 1994-11-22 1996-05-30 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
WO1996032136A1 (en) * 1995-04-10 1996-10-17 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
WO1998005689A1 (en) * 1996-08-02 1998-02-12 Duke University Medical Center Polymers for delivering nitric oxide in vivo
WO2001026702A2 (en) * 1999-10-08 2001-04-19 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses therefor
US6451337B1 (en) * 1998-11-25 2002-09-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US20020155174A1 (en) * 1999-06-11 2002-10-24 Aberdeen University, A Great Britain Corporation Acidified nitrite as an antimicrobial agent
US20030012816A1 (en) * 1999-09-02 2003-01-16 West Jennifer L Nitric oxide-producing hydrogel materials
WO2003092763A1 (en) * 2002-05-03 2003-11-13 Duke University Carbon nanotubules for storage of nitric oxide

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2106105A1 (en) * 1993-09-14 1995-03-15 Larry K. Keefer Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
WO1995024908A1 (en) * 1994-03-17 1995-09-21 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of nitric oxide-releasing polymers to treat restenosis and related disorders
WO1996015797A1 (en) * 1994-11-22 1996-05-30 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
WO1996032136A1 (en) * 1995-04-10 1996-10-17 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
WO1998005689A1 (en) * 1996-08-02 1998-02-12 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US6451337B1 (en) * 1998-11-25 2002-09-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US20020155174A1 (en) * 1999-06-11 2002-10-24 Aberdeen University, A Great Britain Corporation Acidified nitrite as an antimicrobial agent
US20030012816A1 (en) * 1999-09-02 2003-01-16 West Jennifer L Nitric oxide-producing hydrogel materials
WO2001026702A2 (en) * 1999-10-08 2001-04-19 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses therefor
WO2003092763A1 (en) * 2002-05-03 2003-11-13 Duke University Carbon nanotubules for storage of nitric oxide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PULFER S K ET AL: "INCORPORATION OF NITRIC OXIDE-RELEASING CROSSLINKED POLYETHYLENEIMINE MICROSPHERES INTO VASCULAR GRAFTS", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, WILEY, NEW YORK, NY, US, vol. 37, no. 2, November 1997 (1997-11-01), pages 182 - 189, XP000978327, ISSN: 0021-9304 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9526738B2 (en) 2009-08-21 2016-12-27 Novan, Inc. Topical gels and methods of using the same

Also Published As

Publication number Publication date
WO2006084914A2 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
WO2006084912A8 (en) Device method, and use for treatment of neuropathy involving nitric oxide
WO2006084914A3 (en) Device for gastric treatment and manufacturing process for the same
WO2006084910A3 (en) Device and method for treatment of dermatomycosis, and in particular onychomycosis
WO2006084911A3 (en) Improved device for application of medicaments, manufacturing method therefor, and method of treatment
WO2005081788A3 (en) High throughput surface treatment on coiled flexible substrates
WO2006084913A3 (en) Device for treatment of rectal disorders, and manufacturing process for the same, involving nitric oxide
WO2007062008A3 (en) Surface treatment of metallic articles in an atmospheric furnace
WO2006099413A3 (en) Devices, methods and kits for radiation treatment via a target body surface
DE602006006432D1 (en) COSMETIC TREATMENT WITH STAIN OXIDE, DEVICE FOR CARRYING OUT THIS TREATMENT, AND METHOD OF MANUFACTURING THEREOF
JP2005253959A5 (en)
EP1550456A3 (en) Use of botulinum toxin in the treatment of burn pain
WO2005107730A3 (en) Cysteamines for treating complications of hypercholesterolemia and diabetes
TW200620465A (en) Substrate treatment device and manufacturing method for semiconductor device
Ju et al. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis
WO2005084295A3 (en) Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
Huang et al. Laparoscopic suprapancreatic lymph node dissection for advanced gastric cancer using a left-sided approach
AU2003276623A8 (en) Manufacturing process of detachable substrates
AU2003265749A1 (en) Composition for treating substrate and process of treatment
WO2007072218A3 (en) Formulations containing glimepiride and/or its salts
EP1693886A4 (en) Substrate treatment device control method and substrate treatment device
WO2007031853A3 (en) Therapeutic combination of hamlet and a hdac inhibitor to treat cancer
WO2004080477A8 (en) Aplidine for multiple myeloma treatment
JP2004261730A5 (en) Water treatment system
WO2005094282A3 (en) Combination therapy comprising cloretazinetm

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06708232

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6708232

Country of ref document: EP